Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Generation of a Novel Mesothelin-Targeted Oncolytic Herpes Virus and Implemented Strategies for Manufacturing.

Autor: Froechlich, Guendalina¹ (AUTHOR) froechlich@ceinge.unina.it, Gentile, Chiara^1,2 (AUTHOR) carmen.caiazza@unina.it, Infante, Luigia³ (AUTHOR) luigia.infante@ibbc.cnr.it, Caiazza, Carmen² (AUTHOR) massimo.mallardo@unina.it, Pagano, Pasqualina^1,2 (AUTHOR) pasqualina.pagano2@unina.it, Scatigna, Sarah^1,2 (AUTHOR) sarahscatigna@gmail.com, Cotugno, Gabriella³ (AUTHOR) g.cotugno@nouscom.com, D'Alise, Anna Morena³ (AUTHOR) m.dalise@nouscom.com, Lahm, Armin³ (AUTHOR) a.lahm@nouscom.com, Scarselli, Elisa³ (AUTHOR) e.scarselli@nouscom.com, Nicosia, Alfredo^1,2,3 (AUTHOR) nicosia@ceinge.unina.it, Mallardo, Massimo² (AUTHOR), Sasso, Emanuele^1,2,3 (AUTHOR) e.sasso@nouscom.com, Zambrano, Nicola^1,2 (AUTHOR) e.sasso@nouscom.com

Publikováno v: International Journal of Molecular Sciences. Jan2021, Vol. 22 Issue 2, p477-477. 1p.

Uric acid in relapsing–remitting multiple sclerosis: a 2-year longitudinal study

Autor: Carla De Luca Picione, Michele Vastola, Roberta Lanzillo, Marcello Moccia, Giorgia Teresa Maniscalco, Raffaele Palladino, Gabriella Sasso, Teresa Costabile, Antonio Carotenuto, Emanuela Postiglione, Cinzia Valeria Russo, Vincenzo Brescia Morra

Uric acid (UA) is reduced in multiple sclerosis (MS), and possibly relates to MS outcomes, with lower UA levels in subjects experiencing a relapse or presenting higher disability scores. The present retrospective longitudinal study evaluated UA varia

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdcd89e48b39d8be7b0ce708eb5b182c
http://hdl.handle.net/11588/645371